Prostate SBRT 2026

Full Conference Video

Day 1 General Sessions

Opening Jonathan Haas, M.D.
Long-term Outcomes: Five-fraction SBRT Versus Other RT Modalities
Slides
Madhur Garg, M.D., MBA, FACR,
Global Trends in Radiation Oncology
Slides
Alison Tree, M.D.
Is the Current Risk Stratification (ie, NCCN) Still Relevant in the Era of Genomics/AI
Slides Not Available
Michael Zelefsky, M.D.
Optimizing QOL Post SBRT/Strategies to Reduce Toxicity with SBRT
Slides
Sean P. Collins, M.D., Ph.D.
Adaptive Radiotherapy & Treatment Personalization
Video
Slides
Hina Saeed, M.D.
Ultra-hypofractionation Beyond 5 Fractions: 3 Fractions, 2, 1, etc.
Slides
Richard Stock, M.D.
The Role of ADT with SBRT Integration of Traditional and New Hormonal Therapies with Prostate SBRT: Determining the Optimal Timing and Patient Selection
Slides
Daniel Spratt, M.D.
Advancing SBRT Planning: Innovations in MR/CT Imaging and Contouring Techniques
Slides
Daniel Spratt, M.D.
Opportunistic Dose Escalation/De-Escalation, Including DIL and Radiosensitive Subanatomy
Slides Not Available
Michael Zelefsky, M.D

Day 2 General Sessions

SBRT in Oligometastatic Prostate Cancer: A Targeted Approach to the Primary Site and Metastatic Foci
Slides
Alison Tree, M.D.
Emerging Trends and Future Directions in Prostate SBRT
Slides
Seth Blacksburg, M.D.
Optimizing Pelvic Radiotherapy in the PSMA/PET Era: When and How to Integrate SBRT for Nodal Management
Slides
Mack Roach, M.D., Ph.D.
Addressing Prostate SBRT Side Effects: Uro-Oncologic Insights and Thoughts
Slides
Lee Richstone, M.D.
Definitive Focal SBRT: Are We Ready to Compete with Cryotherapy, HIFU, and Laser Ablation Techniques?
Slides
Madhur Garg, M.D., MBA, FACR
Defining Eligibility for Theranostics: Evolving Criteria
Slides
Richard Stock, M.D.
Safety, Toxicity, and Management of Side Effects in Radiopharmaceutical Therapy
Slides
Hina Saeed, M.D.
Clinical Experience with Lutetium-177 PSMA Therapy
Slides
Sean Collins, M.D., Ph.D.
Long-term Efficacy of Salvage SBRT for (Radio) Recurrent Prostate Cancer
Slides
Donald Fuller, M.D.
Role of Biopsy, MRI, and PSMA PET/CT in Guiding Salvage RT (“What the F#$$% Am I Treating?”)
Slides
Donald Fuller, M.D.
Debate: CrossFire with Surgery and Radiation: Comparing Salvage SBRT with Other Salvage Modalities (e.g., Surgery, HIFU, Cryotherapy, LDR, HDR)
Slides – Dr. Richstone
Slides – Dr. Roach
Lee Richstone, M.D.
Mack Roach, M.D., Ph.D.
Challenging Cases + Whoops
Slides
Jonathan Haas, M.D.

Physics Sessions (Slides Only)

On The Use Of Biomathematical Principles In SBRT: Understanding Efficacy And SafetyWolfgang Tome, Ph.D.
CyberKnife® for Prostate SBRTMatthew Witten, Ph.D.
Challenges in Prostate SBRT Treatment PlanningMatthew Witten, Ph.D.
Adaptive SBRT: Initial Experience and Where Prostate SBRT Stands to GainCharlie Ma, Ph.D.
Motion Management in Prostate SBRTLee Goddard, Ph.D.
Expanding SBRT to High-Risk DiseaseLee Goddard, Ph.D.

RTT Sessions (Slides Only)

Prostate SBRT Essentials: What Every RTT Should Know Sean P. Collins, M.D., Ph.D.
IGRT & Treatment Delivery: Accuracy in Action Jordan Johnson, MSHA
Patient Communication & Coaching for SBRT SuccessKaren Crowther, MSc
Implementing Prostate SBRT in Your Department Vance Keeling, Med. Phys.
Debate: Advanced Practice Radiation Therapists: Progress or Overreach?Karen Crowther, MSc
Jordan Johnson, MSHA